Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Yoshio Honma

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Physiology

Anatomy

Disorders

Chemicals & Drugs

Living Beings

Mice

Phenomena

Drug Synergism

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
51
Okabe-Kado, Junko
47
Kasukabe, Takashi
19
Yamamoto-Yamaguchi, Yuri
13
Niitsu, Nozomi
12
Makishima, M
11
Kanatani, Y
9
Motoyoshi, Kazuo
8
Nagata, Naokazu
8
Ishii, Yuki
8
Tomoyasu, Shigeru
8
Umeda, M
6
Asahi, Ken-ichi
4
Nakamaki, Tsuyoshi
4
Wakimoto, Naoki
4
Sassa, Takeshi

Sign-in to see all Coauthors

Publications

TOP 3
Okabe-Kado Junko; Kasukabe Takashi; Honma Yoshio; Kobayashi Hirofumi; Maseki Nobuo; Kaneko Yasuhiko
Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells.
Okabe-Kado Junko; Kasukabe Takashi; Honma Yoshio; Kobayashi Hirofumi; Maseki Nobuo; Kaneko Yasuhiko
Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production.
Tsumura H; Akimoto M; Kiyota H; Ishii Y; Ishikura H; Honma Y
Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Yoshio Honma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Okabe-Kado Junko; Kasukabe Takashi; Honma Yoshio; Kobayashi Hirofumi; Maseki Nobuo; Kaneko Yasuhiko
Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells.
Cancer science 2009;100(10):1885-94.
2009: Okabe-Kado Junko; Kasukabe Takashi; Honma Yoshio; Kobayashi Hirofumi; Maseki Nobuo; Kaneko Yasuhiko
Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production.
International journal of hematology 2009;90(2):143-52.
2009: Tsumura H; Akimoto M; Kiyota H; Ishii Y; Ishikura H; Honma Y
Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(4):753-60.
2008: Kasukabe Takashi; Okabe-Kado Junko; Honma Yoshio
Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2.
Cancer science 2008;99(8):1693-8.
2008: Horie Akiyoshi; Akimoto Miho; Tsumura Hiroto; Makishima Makoto; Taketani Takeshi; Yamaguchi Seiji; Honma Yoshio
Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A.
Leukemia research 2008;32(7):1112-23.
2007: Honma Yoshio; Akimoto Miho
Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents.
Cancer science 2007;98(11):1643-51.
2006: Matsunawa Manabu; Ishii Yuki; Kasukabe Takashi; Tomoyasu Shigeru; Ota Hidekazu; Honma Yoshio
Cotylenin A-induced differentiation is independent of the transforming growth factor-beta signaling system in human myeloid leukemia HL-60 cells.
Leukemia & lymphoma 2006;47(4):733-40.
2005: Honma Yoshio; Kasukabe Takashi; Yamori Takao; Kato Nobuo; Sassa Takeshi
Antitumor effect of cotylenin A plus interferon-alpha: possible therapeutic agents against ovary carcinoma.
Gynecologic oncology 2005;99(3):680-8.
2005: Okabe-Kado Junko; Kasukabe Takashi; Honma Yoshio; Hanada Ryoji; Nakagawara Akira; Kaneko Yasuhiko
Clinical significance of serum NM23-H1 protein in neuroblastoma.
Cancer science 2005;96(10):653-60.
2005: Ishii Yuki; Kasukabe Takashi; Honma Yoshio
Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells.
Biochimica et biophysica acta 2005;1745(2):156-65.
2005: Honma Yoshio
[LIF (leukemia inhibitory factor)]
Nippon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 8():123-4.
2005: Ishii Yuki; Kasukabe Takashi; Honma Yoshio
Induction of CCAAT/enhancer binding protein-delta by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cells.
British journal of haematology 2005;128(4):540-7.
2005: Kasukabe Takashi; Okabe-Kado Junko; Kato Nobuo; Sassa Takeshi; Honma Yoshio
Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts.
Breast cancer research : BCR 2005;7(6):R1097-110.
2004: Ishii Y; Kiyota H; Sakai S; Honma Y
Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(8):1413-9.
2004: Iijima Kimiko; Honma Yoshio; Niitsu Nozomi
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid.
Leukemia & lymphoma 2004;45(5):1017-24.
2004: Yokoyama Akihiro; Yamashita Takuya; Shiozawa Eisuke; Nagasawa Atsuko; Okabe-Kado Junko; Nakamaki Tsuyoshi; Tomoyasu Shigeru; Kimura Fumihiko; Motoyoshi Kazuo; Honma Yoshio; Kasukabe Takashi
MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia.
Leukemia research 2004;28(2):149-57.
2003: Honma Yoshio; Ishii Yuki; Sassa Takeshi; Asahi Ken-ichi
Treatment of human promyelocytic leukemia in the SCID mouse model with cotylenin A, an inducer of myelomonocytic differentiation of leukemia cells.
Leukemia research 2003;27(11):1019-25.
2003: Nakamaki Tsuyoshi; Hamano Yasuharu; Hisatake Jun-Ichi; Yokoyama Akihiro; Kawakami Kei-Ichiro; Tomoyasu Shigeru; Honma Yoshio; Koeffler Phillip
Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival.
British journal of haematology 2003;123(1):72-80.
2003: Honma Yoshio; Ishii Yuki; Yamamoto-Yamaguchi Yuri; Sassa Takeshi; Asahi Ken-ichi
Cotylenin A, a differentiation-inducing agent, and IFN-alpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude mice.
Cancer research 2003;63(13):3659-66.
2003: Yamamoto-Yamaguchi Yuri; Okabe-Kado Junko; Kasukabe Takashi; Honma Yoshio
Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells.
Anticancer research 2003;23(3B):2537-47.
2002: Honma Yoshio; Ishii Yuki
Differentiation of human myeloid leukemia cells by plant redifferentiation-inducing hormones.
Leukemia & lymphoma 2002;43(9):1729-35.
2002: Honma Yoshio
Cotylenin A--a plant growth regulator as a differentiation-inducing agent against myeloid leukemia.
Leukemia & lymphoma 2002;43(6):1169-78.
2002: Okabe-Kado Junko; Kasukabe Takashi; Honma Yoshio
Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages.
Leukemia research 2002;26(6):569-76.
2002: Nakamaki Tsuyoshi; Okabe-Kado Junko; Yamamoto-Yamaguchi Yuri; Hino Ken ichiro; Tomoyasu Shigeru; Honma Yoshio; Kasukabe Takashi
Role of MmTRA1b/phospholipid scramblase1 gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes.
Experimental hematology 2002;30(5):421-9.
2002: Ishii Yuki; Hori Yuko; Sakai Shingo; Honma Yoshio
Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2002;13(1):19-26.
2001: Honma Y
A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors.
Leukemia & lymphoma 2001;42(5):953-62.
2001: Yamada K; Honma Y; Asahi K I; Sassa T; Hino K I; Tomoyasu S
Differentiation of human acute myeloid leukaemia cells in primary culture in response to cotylenin A, a plant growth regulator.
British journal of haematology 2001;114(4):814-21.
2001: Ishii Y; Sakai S; Honma Y
Pyridinyl imidazole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells.
Leukemia research 2001;25(9):813-20.
2001: Yamamoto-Yamaguchi Y; Okabe-Kado J; Kasukabe T; Honma Y
Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors.
Experimental hematology 2001;29(5):582-8.
2001: Yamamoto-Yamaguchi Y; Yamada K; Ishii Y; Asahi K I; Tomoyasu S; Honma Y
Induction of the monocytic differentiation of myeloid leukaemia cells by cotylenin A, a plant growth regulator.
British journal of haematology 2001;112(3):697-705.
2001: Niitsu N; Okabe-Kado J; Okamoto M; Takagi T; Yoshida T; Aoki S; Hirano M; Honma Y
Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
Blood 2001;97(5):1202-10.
2001: Niitsu N; Hayashi Y; Sugita K; Honma Y
Sensitization by 5-aza-2'-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3.
British journal of haematology 2001;112(2):315-26.
2001: Honma Y; Ishii Y; Kasukabe T; Okabe-Kado J; Yamamoto-Yamaguchi Y; Kakegawa T; Awaya A
Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives.
Experimental hematology 2001;29(2):194-201.
2001: Niitsu N; Hayashi Y; Honma Y
Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13).
Oncogene 2001;20(3):375-84.
2001: Niitsu N; Ishii Y; Matsuda A; Honma Y
Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Cancer research 2001;61(1):178-85.
2000: Honma Y; Niitsu N
Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia.
Leukemia & lymphoma 2000;39(1-2):57-66.
2000: Niitsu N; Yamamoto-Yamaguchi Y; Kasukabe T; Okabe-Kado J; Umeda M; Honma Y
Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells.
Blood 2000;96(4):1512-6.
2000: Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
Blood 2000;96(3):1080-6.
2000: Niitsu N; Kasukabe T; Yokoyama A; Okabe-Kado J; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
Anticancer derivative of butyric acid (Pivalyloxymethyl butyrate) specifically potentiates the cytotoxicity of doxorubicin and daunorubicin through the suppression of microsomal glycosidic activity.
Molecular pharmacology 2000;58(1):27-36.
2000: Niitsu N; Umeda M; Honma Y
Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
Leukemia research 2000;24(1):1-9.
1999: Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
Blood 1999;94(10):3541-50.
1999: Kanatani Y; Kasukabe T; Okabe-Kado J; Yamamoto-Yamaguchi Y; Nagata N; Motoyoshi K; Honma Y
Role of CD14 expression in the differentiation-apoptosis switch in human monocytic leukemia cells treated with 1alpha,25-dihydroxyvitamin D3 or dexamethasone in the presence of transforming growth factor beta1.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999;10(10):705-12.
1999: Niitsu N; Honma Y
Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
Leukemia & lymphoma 1999;34(3-4):261-71.
1999: Honma Y; Yamamoto-Yamaguchi Y; Kanatani Y
Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice.
British journal of cancer 1999;80(1-2):96-103.
1999: Makishima M; Shudo K; Honma Y
Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
Biochemical pharmacology 1999;57(5):521-9.
1998: Okabe-Kado J; Kasukabe T; Honma Y
Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.
Leukemia & lymphoma 1998;32(1-2):19-28.
1998: Niitsu N; Yamaguchi Y; Umeda M; Honma Y
Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Blood 1998;92(9):3368-75.
1998: Kasukabe T; Kobayashi H; Kaneko Y; Okabe-Kado J; Honma Y
Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesis-associated gene (MmTRA1a) product as plasma membrane phospholipid scramblase and chromosome mapping of the human MmTRA1b/phospholipid scramblase gene.
Biochemical and biophysical research communications 1998;249(2):449-55.
1998: Honma Y; Tobe H; Makishima M; Yokoyama A; Okabe-Kado J
Induction of differentiation of myelogenous leukemia cells by humulone, a bitter in the hop.
Leukemia research 1998;22(7):605-10.
1998: Yamada K; Hino K; Tomoyasu S; Honma Y; Tsuruoka N
Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture.
Leukemia research 1998;22(7):589-95.
1998: Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
British journal of cancer 1998;77(12):2298-303.
1998: Makishima M; Umesono K; Shudo K; Naoe T; Kishi K; Honma Y
Induction of differentiation in acute promyelocytic leukemia cells by 9-cis retinoic acid alpha-tocopherol ester (9-cis tretinoin tocoferil).
Blood 1998;91(12):4715-26.
1998: Wakimoto N; Yokoyama A; Mukai Y; Kuwada N; Yamashita T; Matsumura T; Nakamura Y; Kanatani Y; Nagata N; Okabe-Kado J; Honma Y; Motoyoshi K
Elevated expression of differentiation inhibitory factor nm23 mRNA in monoblastic crisis of a patient with chronic myelogenous leukemia.
International journal of hematology 1998;67(3):313-8.
1998: Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y
A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Experimental hematology 1998;26(3):198-206.
1998: Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino K i; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
Blood 1998;91(6):1845-51.
1998: Makishima M; Okabe-Kado J; Honma Y
Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea.
British journal of cancer 1998;77(1):33-9.
1997: Niitsu N; Yamamoto-Yamaguchi Y; Kanatani Y; Shuto S; Matsuda A; Umeda M; Honma Y
Neplanocin A, a potent inhibitor of S-adenosylhomocysteine hydrolase, potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid.
Experimental hematology 1997;25(12):1296-303.
1997: Kanatani Y; Makishima M; Asahi K; Sakurai A; Takahashi N; Motoyoshi K; Nagata N; Honma Y
Differanisole A, a novel antitumor antibiotic, enhances growth inhibition and differentiation of human myeloid leukemia cells induced by 9-cis retinoic acid.
Biochimica et biophysica acta 1997;1359(1):71-9.
1997: Asahi K; Honma Y; Hazeki K; Sassa T; Kubohara Y; Sakurai A; Takahashi N
Cotylenin A, a plant-growth regulator, induces the differentiation in murine and human myeloid leukemia cells.
Biochemical and biophysical research communications 1997;238(3):758-63.
1997: Niitsu N; Umeda M; Honma Y
Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
Biochemical and biophysical research communications 1997;238(1):100-6.
1997: Makishima M; Honma Y
Tretinoin tocoferil as a possible differentiation-inducing agent against myelomonocytic leukemia.
Leukemia & lymphoma 1997;26(1-2):43-8.
1997: Kasukabe T; Okabe-Kado J; Honma Y
TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines.
Blood 1997;89(8):2975-85.
1997: Niitsu N; Yamamoto-Yamaguchi Y; Miyoshi H; Shimizu K; Ohki M; Umeda M; Honma Y
AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(3):319-26.
1996: Makishima M; Honma Y
Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells.
Leukemia research 1996;20(9):781-9.
1996: Goto I; Yamamoto-Yamaguchi Y; Honma Y
Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents.
British journal of cancer 1996;74(4):546-54.
1996: Yokoyama A; Okabe-Kado J; Uehara Y; Oki T; Tomoyasu S; Tsuruoka N; Honma Y
Angelmicin B, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells.
Leukemia research 1996;20(6):491-7.
1996: Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Experimental hematology 1996;24(6):682-9.
1996: Makishima M; Kanatani Y; Yamamoto-Yamaguchi Y; Honma Y
Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
Blood 1996;87(8):3384-94.
1996: Kanatani Y; Kasukabe T; Okabe-Kado J; Hayashi S; Yamamoto-Yamaguchi Y; Motoyoshi K; Nagata N; Honma Y
Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1996;7(2):187-96.
1996: Sato S; Tomoyasu S; Okabe-Kado J; Hozumi M; Tsuruoka N; Nakai S; Adachi M; Honma Y
Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
Experimental hematology 1996;24(1):37-42.
1995: Makishima M; Yamamoto-Yamaguchi Y; Honma Y
19-Allylaminoherbimycin A, an analog of herbimycin A that is stable against treatment with thiol compounds or granulocyte-macrophage colony-stimulating factor in human leukemia cells.
Biochimica et biophysica acta 1995;1272(3):199-205.
1995: Okabe-Kado J; Kasukabe T; Baba H; Urano T; Shiku H; Honma Y
Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells.
Biochimica et biophysica acta 1995;1267(2-3):101-6.
1995: Okabe-Kado J; Kasukabe T; Hozumi M; Honma Y; Kimura N; Baba H; Urano T; Shiku H
A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activity.
FEBS letters 1995;363(3):311-5.
1995: Honma Y; Matsuo Y; Hayashi Y; Omura S
Treatment of Philadelphia-chromosome-positive human leukemia in SCID mouse model with herbimycin A, bcr-abl tyrosine kinase activity inhibitor.
International journal of cancer. Journal international du cancer 1995;60(5):685-8.
1994: Honma Y
Acycloguanosine and herbimycin A co-operatively inhibit proliferation and induce erythrodifferentiation of human myeloid leukemia K562 cells.
Leukemia research 1994;18(11):851-4.
1994: Sato S; Honma Y; Hozumi M; Hayashi Y; Matsuo Y; Shibata K; Omura S; Hino K; Tomoyasu S; Tsuruoka N
Effects of herbimycin A and its derivatives on growth and differentiation of Ph1-positive acute lymphoid leukemia cell lines.
Leukemia research 1994;18(3):221-8.
1994: Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Cancer research 1994;54(2):592-7.
1993: Kanatani Y; Kasukabe T; Hozumi M; Motoyoshi K; Nagata N; Honma Y
Genistein exhibits preferential cytotoxicity to a leukemogenic variant but induces differentiation of a non-leukemogenic variant of the mouse monocytic leukemia Mm cell line.
Leukemia research 1993;17(10):847-53.
1993: Kanatani Y; Honma Y; Tsuchimochi T; Okabe-Kado J; Nagata N; Motoyoshi K; Hozumi M
Induction of differentiation and growth suppression of myeloid leukemia cells by sera of patients with hematological disorders.
Anticancer research 1993;13(5C):1905-11.
1993: Honma Y; Nakamaki T; Tsuruoka N
[Role of cytokines in differentiation therapy with retinoic acid]
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(8):1022-7.
1993: Makishima M; Honma Y; Hozumi M; Nagata N; Motoyoshi K
Differentiation of human monoblastic leukemia U937 cells induced by inhibitors of myosin light chain kinase and prevention of differentiation by granulocyte-macrophage colony-stimulating factor.
Biochimica et biophysica acta 1993;1176(3):245-9.
1992: Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
Interleukin 4 potentiates the antiproliferative effect of 1 alpha, 25-dihydroxyvitamin D3 on mouse monocytic leukemia cells but antagonizes the antiproliferative effects of interferon alpha, beta and interleukin 6.
Leukemia research 1992;16(12):1191-6.
1992: Honma Y; Kasukabe T; Hozumi M
Control of growth and differentiation of Philadelphia chromosome-positive leukemia cells by tyrosine kinase inhibitors.
The Tohoku journal of experimental medicine 1992;168(2):387-91.
1992: Okabe-Kado J; Honma Y; Kasukabe T; Hozumi M
Synthesis of active metabolite(s) from 1 alpha-hydroxyvitamin D3 by human monocytic leukemia cells.
FEBS letters 1992;309(3):399-401.
1992: Honma Y; Okabe-Kado J; Kasukabe T; Hozumi M; Kodama H; Kajigaya S; Suda T; Miura Y
Herbimycin A, an inhibitor of tyrosine kinase, prolongs survival of mice inoculated with myeloid leukemia C1 cells with high expression of v-abl tyrosine kinase.
Cancer research 1992;52(14):4017-20.
1992: Okabe-Kado J; Kasukabe T; Honma Y; Hayashi M; Henzel W J; Hozumi M
Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase.
Biochemical and biophysical research communications 1992;182(3):987-94.
1992: Honma Y; Kasukabe T; Hozumi M; Shibata K; Omura S
Effects of herbimycin A derivatives on growth and differentiation of K562 human leukemic cells.
Anticancer research 1992;12(1):189-92.
1992: Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M; Matsuda T; Hirano T
Characterization of growth inhibitory factors for mouse monocytic leukemia cells.
Leukemia research 1992;16(2):139-44.
1991: Honma Y; Kasukabe T; Hozumi M; Akimoto H; Nomura H
Induction of differentiation of human myeloid leukemia HL-60 cells by novel nonphosphorus alkyl ether lipids.
Lipids 1991;26(12):1445-9.
1991: Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
Interleukin-4 inhibits the differentiation of mouse myeloid leukemia M1 cells induced by dexamethasone, D-factor/leukemia inhibitory factor and interleukin-6, but not by 1 alpha,25-dihydroxyvitamin D3.
FEBS letters 1991;291(2):181-4.
1991: Honma Y; Onozuka Y; Okabe-Kado J; Kasukabe T; Hozumi M
Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
Cancer research 1991;51(17):4535-8.
1991: Honma Y; Okabe-Kado J; Kasukabe T; Hozumi M; Kajigaya S; Suda T; Miura Y
Induction by some protein kinase inhibitors of differentiation of a mouse megakaryoblastic cell line established by coinfection with Abelson murine leukemia virus and recombinant SV40 retrovirus.
Cancer research 1991;51(17):4649-55.
1991: Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Tsuruo T
Inhibition by erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells.
Cancer research 1991;51(10):2582-6.
1991: Okabe-Kado J; Honma Y; Hayashi M; Hozumi M
Effects of transforming growth factor-beta and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells.
Anticancer research 1991;11(1):181-6.
1991: Okabe-Kado J; Honma Y; Hozumi M
Inhibition by vitamin D3 of erythroid differentiation of human leukemia line cells induced by transforming growth factor beta or erythroid differentiation factor (activin A).
Leukemia research 1991;15(8):721-6.
1990: Kasukabe T; Honma Y; Hozumi M; Nomura H
Inhibition of proliferation and induction of differentiation of human and mouse myeloid leukemia cells by new ethyleneglycol-type nonphosphorus alkyl ether lipids.
Japanese journal of cancer research : Gann 1990;81(8):807-12.
1990: Hozumi M; Tomida M; Yamamoto-Yamaguchi Y; Kasukabe T; Okabe-Kado J; Honma Y; Hayashi M
Protein factors that regulate the growth and differentiation of mouse myeloid leukaemia cells.
Ciba Foundation symposium 1990;148():25-33; discussion 33-42.
1989: Okabe-Kado J; Honma Y; Hayashi M; Hozumi M
Inhibitory action of transforming growth factor-beta on induction of differentiation of myeloid leukemia cells.
Japanese journal of cancer research : Gann 1989;80(3):228-32.
1989: Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
Cancer research 1989;49(2):331-4.
1989: Ikuta T; Honma Y; Okabe-Kado J; Kasukabe T; Hozumi M
Normal mouse lung tissue produces a growth-inhibitory factor(s) preferential for mouse monocytic leukemia cells.
Cancer immunology, immunotherapy : CII 1989;30(3):139-44.
1988: Okabe-Kado J; Kasukabe T; Honma Y; Hayashi M; Hozumi M
Purification of a factor inhibiting differentiation from conditioned medium of nondifferentiating mouse myeloid leukemia cells.
The Journal of biological chemistry 1988;263(22):10994-9.
1988: Honma Y; Ikuta T; Kasukabe T; Hozumi M; Itoh T; Ogura H
Inhibition of proliferation and induction of differentiation of human myeloid leukemia cells by novel nucleoside analogs.
Anticancer research 1988;8(4):695-9.
1988: Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
Purification of a novel growth inhibitory factor for partially differentiated myeloid leukemic cells.
The Journal of biological chemistry 1988;263(11):5431-5.
1988: Hozumi M; Honma Y; Kasukabe T; Hayashi M; Okabe-Kado J
Modification by vitamins and nutrients of induction of terminal differentiation of myeloid leukemia cells.
Progress in clinical and biological research 1988;259():131-48.
1987: Kasukabe T; Okabe-Kado J; Honma Y; Hozumi M
Production by undifferentiated myeloid leukemia cells of a novel growth-inhibitory factor(s) for partially differentiated myeloid leukemic cells.
Japanese journal of cancer research : Gann 1987;78(9):921-31.

Sign-in to see more